Simon B. Drysdale

机构：University of Oxford, Oxford BioMedica (United Kingdom) · ORCID：0000-0002-6350-6557

发表论文 172 篇 · 总被引 7608 次 · h-index 37

代表论文

• The recent landscape of RSV vaccine research (2025 · Therapeutic Advances in Vaccines and Immunotherapy · 被引 55)
• 180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial (2025 · The Lancet Child & Adolescent Health · 被引 52)
• Bivalent prefusion F vaccination in pregnancy and respiratory syncytial virus hospitalisation in infants in the UK: results of a multicentre, test-negative, case-control study (2025 · The Lancet Child & Adolescent Health · 被引 33)
• Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis (2025 · EClinicalMedicine · 被引 29)
• Real-world effectiveness and safety of nirsevimab, RSV maternal vaccine and RSV vaccines for older adults: a living systematic review and meta-analysis (2025 · Thorax · 被引 20)
• Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2025 · The Lancet Infectious Diseases · 被引 10)